FDA Inspection 1325870 — Biomat USA Inc

Biomat USA Inc — FEI 3014126875

The FDA completed an inspection of Biomat USA Inc on Jun 30, 2026 in Channelview, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jun 30, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Channelview, TX (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.